Antibiotech vs Medial EarlySign
Antibiotech vs Medial EarlySign, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Antibiotech is on 30/100 and Medial EarlySign on 49/100.
Where each one leads
Antibiotech
Leads on none of the measures we hold for both companies.
Medial EarlySign
- our overall score: 49/100 against 30/100
- headcount: 8 against 3
At a glance
| Measure | Antibiotech | Medial EarlySign |
|---|---|---|
| What it is | AI-powered decision support for personalized antibiotic treatment recommendations. | Develops AI-powered decision support tools for personalized medical data interpretation and prediction. |
| Category | Healthcare, Digital Health, Decision Support, HealthTech | Healthcare, Decision Support, Insights, Detection |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2019 | 2009 |
| Headquarters | Tel Aviv, Israel | Tel Aviv, Israel |
| Status | Inactive | Inactive |
Size, funding and growth
| Measure | Antibiotech | Medial EarlySign |
|---|---|---|
| Employees | 3 | 8 |
| Headcount growthLast 12 months | Not published | -26.4% |
| Total funding | Not published | $50.0M |
| Latest round | Not published | Series B |
| LinkedIn followers | Not published | 2,122 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Antibiotech | Medial EarlySign |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 30/100 | 49/100 |
| Traction | 6/100 | 48/100 |
| Team | 60/100 | 20/100 |
| Community | Not published | 15/100 |
| Search visibility | 8/100 | 29/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | F (22/100) |
| Domain ratingLink authority, 0-100 | Not published | 31/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Antibiotech | Medial EarlySign |
|---|---|---|
| Hosting | OVH | Not detected |
Antibiotech vs Medial EarlySign: common questions
Which is better, Antibiotech or Medial EarlySign?
On our 0-100 score Medial EarlySign rates higher (49/100 against 30/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
How do Antibiotech and Medial EarlySign compare on the numbers?
Medial EarlySign leads on our overall score (49/100 against 30/100), headcount (8 against 3).
Read the full Antibiotech review and pricing or the Medial EarlySign review and pricing. You can also browse other Antibiotech alternatives we track.